FDA Details Risk Reduction In Biologic Clinical Trials
The U.S. Food and Drug Administration released guidance describing how drugmakers involved in cellular and gene therapy can structure early stage clinical trials, describing the approaches needed to minimize the distinct...To view the full article, register now.
Already a subscriber? Click here to view full article